Massimo Ghizzoni

510 total citations
9 papers, 400 citations indexed

About

Massimo Ghizzoni is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, Massimo Ghizzoni has authored 9 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 1 paper in Infectious Diseases. Recurrent topics in Massimo Ghizzoni's work include Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Nuclear Receptors and Signaling (2 papers). Massimo Ghizzoni is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Nuclear Receptors and Signaling (2 papers). Massimo Ghizzoni collaborates with scholars based in Netherlands, Poland and United States. Massimo Ghizzoni's co-authors include Frank J. Dekker, Hidde J. Haisma, Harm Maarsingh, Rosalina Wisastra, Jiang Wu, Tielong Gao, Chris de Graaf, Katarzyna Piwocka, Monika Kusio-Kobiałka and Adriaan J. Minnaard and has published in prestigious journals such as Drug Discovery Today, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Massimo Ghizzoni

9 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Ghizzoni Netherlands	9	281	68	57	28	28	9	400
Nagashayana Natesh India	6	369 1.3×	66 1.0×	114 2.0×	16 0.6×	32 1.1×	6	516
Kuei-Li Lin Taiwan	12	284 1.0×	56 0.8×	119 2.1×	28 1.0×	31 1.1×	13	503
Yvette Newbatt United Kingdom	12	451 1.6×	52 0.8×	54 0.9×	6 0.2×	36 1.3×	13	583
Yu-Ping Hsiao Taiwan	12	217 0.8×	27 0.4×	48 0.8×	30 1.1×	49 1.8×	14	399
Sarah Ciccone Italy	10	291 1.0×	15 0.2×	56 1.0×	14 0.5×	81 2.9×	10	501
Natalia Lisiak Poland	13	282 1.0×	32 0.5×	50 0.9×	12 0.4×	40 1.4×	31	446
Sandip Kumar Rath India	14	370 1.3×	14 0.2×	81 1.4×	33 1.2×	28 1.0×	18	519
Vanessa Lopes-Rodrigues Portugal	10	349 1.2×	27 0.4×	103 1.8×	20 0.7×	23 0.8×	19	527
Zi Hui China	13	262 0.9×	127 1.9×	91 1.6×	6 0.2×	21 0.8×	32	453
Archana Katoch India	14	214 0.8×	35 0.5×	98 1.7×	22 0.8×	28 1.0×	19	345

Countries citing papers authored by Massimo Ghizzoni

Since Specialization

Citations

This map shows the geographic impact of Massimo Ghizzoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Ghizzoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Ghizzoni more than expected).

Fields of papers citing papers by Massimo Ghizzoni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Ghizzoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Ghizzoni. The network helps show where Massimo Ghizzoni may publish in the future.

Co-authorship network of co-authors of Massimo Ghizzoni

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Ghizzoni. A scholar is included among the top collaborators of Massimo Ghizzoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Ghizzoni. Massimo Ghizzoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Kusio-Kobiałka, Monika, et al.. (2013). Inhibition of PCAF by Anacardic Acid Derivative Leads to Apoptosis and Breaks Resistance to DNA Damage in BCR-ABL-expressing Cells. Anti-Cancer Agents in Medicinal Chemistry. 13(5). 762–767. 13 indexed citations

Kusio-Kobiałka, Monika, Kamila Wolanin, Paulina Podszywalow‐Bartnicka, et al.. (2012). Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage. APOPTOSIS. 17(9). 950–963. 9 indexed citations

Wisastra, Rosalina, et al.. (2012). Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases. Bioorganic & Medicinal Chemistry. 20(16). 5027–5032. 25 indexed citations

Wisastra, Rosalina, Massimo Ghizzoni, Harm Maarsingh, et al.. (2011). Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF. Organic & Biomolecular Chemistry. 9(6). 1817–1817. 18 indexed citations

Ghizzoni, Massimo, et al.. (2011). 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site. European Journal of Medicinal Chemistry. 47(1). 337–344. 91 indexed citations

Ghizzoni, Massimo, Hidde J. Haisma, Harm Maarsingh, & Frank J. Dekker. (2011). Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation. Drug Discovery Today. 16(11-12). 504–511. 108 indexed citations

Ghizzoni, Massimo, et al.. (2010). Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative. Bioorganic & Medicinal Chemistry. 18(16). 5826–5834. 65 indexed citations

Ghizzoni, Massimo, Hidde J. Haisma, & Frank J. Dekker. (2009). Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase. European Journal of Medicinal Chemistry. 44(12). 4855–4861. 29 indexed citations

Dekker, Frank J., et al.. (2008). Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones. Bioorganic & Medicinal Chemistry. 17(2). 460–466. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact